Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells. Oncotarget. 2017 May 30; 8(22):35863-35876.
View in:
PubMed
subject areas
Aged
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Benzeneacetamides
Biomarkers
Cell Line, Tumor
Cell Respiration
Cell Survival
Drug Resistance, Neoplasm
Drug Synergism
Endoplasmic Reticulum Stress
Energy Metabolism
Glutaminase
Humans
Mitochondria
Multiple Myeloma
Oligopeptides
Proteasome Inhibitors
Thiadiazoles
authors with profiles
Andrzej Jakubowiak